CIK 0001719714
- Non-accelerated filer
- Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 3330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- 4 Open-market sale Chief Executive Officer sold 132,985 shares at an average $3.49 ($463,487)
- 4 Open-market sale Hughes-Wilson Alexandra sold 33,102 shares at an average $3.49 ($115,369)
- 4 Exercise or conversion Chief Scientific Officer acquired 69,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 282,090 shares (option exercise)
- 4 Exercise or conversion General Counsel acquired 98,400 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 90,000 shares (option exercise)
- 4 Exercise or conversion Hughes-Wilson Alexandra acquired 60,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 25,050 shares (grant or award)
- 4 Grant or award Director acquired 12,550 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4 Open-market sale Hughes-Wilson Alexandra sold 100,432 shares at an average $2.97 ($297,788)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 4 · 80 filings